FDA’s Anesthetic and Life Support Drugs Advisory Cmte.
Executive Summary
Will discuss Anaquest's inhalation anesthetic Suprane (desflurane) on Aug. 31 and adverse experience reports related to ICI's Diprivan (propofol) on Sept. 1. Meeting will be held in conference rooms D and E of FDA's Parklawn Building in Rockville, Md., with open portions scheduled from 8:30 to 11:30 a.m. on Aug. 31 and 8:30 to 11 a.m. on Sept. 1.